These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of pluripotent stem cell for personalized cell therapies against neurological disorders. Ha HY; Jang SH; Jung JW J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784 [TBL] [Abstract][Full Text] [Related]
5. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on. Puri MC; Nagy A Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565 [TBL] [Abstract][Full Text] [Related]
6. Concise review: stem cells for the treatment of cerebellar-related disorders. Erceg S; Moreno-Manzano V; Garita-Hernandez M; Stojkovic M; Bhattacharya SS Stem Cells; 2011 Apr; 29(4):564-9. PubMed ID: 21319272 [TBL] [Abstract][Full Text] [Related]
8. From stem cells to dopamine neurons: developmental biology meets neurodegeneration. Tailor J; Andreska T; Kittappa R CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):893-6. PubMed ID: 23131155 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells. López-González R; Velasco I Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229 [TBL] [Abstract][Full Text] [Related]
10. Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations. Desgres M; Menasché P Cell Stem Cell; 2019 Nov; 25(5):594-606. PubMed ID: 31703770 [TBL] [Abstract][Full Text] [Related]
11. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
12. Stem Cell Therapies for Neurodegenerative Diseases. Sugaya K; Vaidya M Adv Exp Med Biol; 2018; 1056():61-84. PubMed ID: 29754175 [TBL] [Abstract][Full Text] [Related]
13. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases. Han F; Lu P Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491 [TBL] [Abstract][Full Text] [Related]
15. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations. Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732 [TBL] [Abstract][Full Text] [Related]
16. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy. Cooper O; Parmar M; Isacson O Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423 [TBL] [Abstract][Full Text] [Related]
17. Stem cell therapies for Parkinson's disease: are trials just around the corner? Drouin-Ouellet J; Barker RA Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072 [No Abstract] [Full Text] [Related]
18. Current status of treating neurodegenerative disease with induced pluripotent stem cells. Pen AE; Jensen UB Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435 [TBL] [Abstract][Full Text] [Related]
19. Stem cells and neurodegenerative diseases. Hou L; Hong T Sci China C Life Sci; 2008 Apr; 51(4):287-94. PubMed ID: 18368305 [TBL] [Abstract][Full Text] [Related]
20. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases. Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]